美国马人工授精市场：市场规模、份额、趋势分析（按解决方案、马匹品种和分销管道划分）、细分市场预测（2025-2033 年）

市场规模与趋势：

据估计，2024 年美国马匹人工授精市场价值为 1.5544 亿美元，预计到 2033 年将达到 2.4783 亿美元，2025 年至 2033 年的复合年增长率为 5.41%。

受竞技马和休閒马日益普及、马匹兽医基础设施不断完善以及监管和育种产业生态系统的支持，马匹市场持续成长。美国拥有约920万匹马，它们在休閒、竞技和工业马匹产业中发挥着至关重要的作用。其中，近390万匹马参与休閒，约270万匹马参加马术比赛。

为了确保幼驹拥有卓越的遗传耐力、敏捷性和性情，马主们越来越多地投资于人工授精（AI）。这种需求涵盖了牛仔竞技、绕桶赛、猎人跳跃赛和马场马术等多个马术项目。透过提供广泛且经过验证的种公马资源，人工授精有助于培育出适合各种竞技需求的马匹。休閒马术产业的蓬勃发展，尤其是在德克萨斯州、肯塔基州和加州等州，持续推动人工授精技术的普及。

目录

第一章 分析方法和范围

第二章执行摘要

第三章美国马匹人工授精市场：驱动因素、趋势与范围

• 市场关联性展望
  • 母市场
  • 附随市场
• 市场动态
  • 市场驱动因素分析
  • 市场限制因素分析
  • 市场机会分析
  • 市场问题分析
• 美国马匹人工授精市场：分析工具
  • 产业分析：波特五力分析
  • PESTEL 分析
• 定价分析
• 法律规范
• 主要国家马匹数量估计（2024 年）

第四章美国马匹人工授精市场：依解决方案分類的估价与趋势分析

• 细分仪表板
• 美国马匹人工授精市场：按解决方案分類的变化分析
• 美国马匹人工授精市场规模及趋势分析（按解决方案划分）（2021-2033 年）
• 设备/耗材
• 精液
• 服务

第五章美国马匹人工授精市场：按马匹品种分類的估计和趋势分析

• 细分仪表板
• 美国马匹人工授精市场：依马匹品种分類的趋势分析
• 美国马匹人工授精市场规模及趋势分析（按马品种划分）（2021-2033 年）
• 运动/赛车
• 休閒
• 其他的

第六章：美国马匹人工授精市场：通路估算与趋势分析

• 细分仪表板
• 美国马匹人工授精市场：按分销管道分類的变化分析
• 美国马匹人工授精市场规模及趋势分析（依通路划分）（2021-2033 年）
  • 私人的
  • 公共

第七章 竞争情势

• 市场参与企业分类
• 企业市场分析/热力图分析
• 公司简介
  • Neogen Corporation
  • Zoetis Services LLC
  • HOFFMAN AI BREEDERS INC
  • Nasco Healthcare
  • IMV Technologies
  • Continental Genetics, LLC
  • Olympia Equine Veterinary Services PLLC
  • Sarasota Equine Veterinary Services
  • Montana Equine Medical and Surgical Center
  • Select Breeders Services
  • Equine Reproduction Concepts, LLC
  • Wisconsin Valley Veterinary Service
• 策略规划
  • 企业合併（M&A）
  • 商业伙伴关係与合作
  • 产品/服务发布
  • 其他的
• 其他主要企业名单

Market Size & Trends:

The U.S. equine artificial insemination market size was estimated at USD 155.44 million in 2024 and is projected to reach USD 247.83 million by 2033, growing at a CAGR of 5.41% from 2025 to 2033. The market is continuously growing, driven by the rising popularity of performance and recreational horses, expanding equine veterinary infrastructure, and a supportive regulatory and breeding industry ecosystem. The professional racing and competition, the growing popularity of recreational riding, show jumping, and Western performance events, are driving demand for high-quality horses in the U.S. The U.S. is home to around 9.2 million horses, playing a vital role in recreation, competition, and the broader equine industry. Among this population, nearly 3.9 million are engaged in recreational activities, while about 2.7 million participate in horse shows, reflecting the strong cultural and economic importance of equestrian pursuits nationwide.

Owners are increasingly investing in artificial insemination (AI) to secure foals with superior genetics for endurance, agility, and temperament. This demand spans disciplines such as rodeo, barrel racing, hunter/jumper circuits, and dressage. By enabling wider access to proven stallions, AI supports the breeding of horses suited to diverse performance needs. The expanding recreational equine sector, particularly in states like Texas, Kentucky, and California, continues to boost AI adoption.

U.S. Equine Artificial Insemination Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. equine artificial insemination market report based on solution, equine, and distribution channel:

• Solution Outlook (Revenue, USD Million, 2021 - 2033)
• Equipment & Consumables
• Semen
  • Normal Semen
  • Sexed Semen
• Services
• Equine Outlook (Revenue, USD Million, 2021 - 2033)
• Sports/Racing
• Recreation
• Other Type
• Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
• Private
• Public

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Sources
  • 1.3.4. Primary Research
  • 1.3.5. Details of Primary Research
  • 1.3.6. Data analysis model
• 1.4. Information/Data Analysis
• 1.5. Market Formulation & Visualization
• 1.6. Data Validation & Publishing
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis
  • 1.7.2. Market: CAGR Calculation
• 1.8. List of Secondary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Equine Artificial Insemination Market Variable Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market
  • 3.1.2. Ancillary Market
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Expanding equine veterinary infrastructure
    • 3.2.1.2. Rising popularity of performance and recreational horses
    • 3.2.1.3. Supportive regulatory and breeding industry ecosystem
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High cost of advanced reproductive procedures.
  • 3.2.3. Market Opportunity Analysis
  • 3.2.4. Market Challenge Analysis
• 3.3. U.S. Equine Artificial Insemination Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitution
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Legal landscape
    • 3.3.2.3. Economic landscape
    • 3.3.2.4. Social landscape
    • 3.3.2.5. Technological landscape
    • 3.3.2.6. Environmental landscape
• 3.4. Pricing Analysis
• 3.5. Regulatory Framework
• 3.6. Estimated Equine Population by key countries, 2024

Chapter 4. U.S. Equine Artificial Insemination Market: Solution Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Equine Artificial Insemination Market: Solution Movement Analysis
• 4.3. U.S. Equine Artificial Insemination Market Size & Trend Analysis, by solution, 2021 to 2033 (USD Million)
• 4.4. Equipment & Consumables
  • 4.4.1. Equipment & Consumables Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Semen
  • 4.5.1. Semen Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.1.1. Normal Semen
      • 4.5.1.1.1. Normal Semen Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.1.2. Sexed Semen
      • 4.5.1.2.1. Sexed Semen Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Services
  • 4.6.1. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Equine Artificial Insemination Market: Equine Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. U.S. Equine Artificial Insemination Market: Equine Movement Analysis
• 5.3. U.S. Equine Artificial Insemination Market Size & Trend Analysis, by Equine, 2021 to 2033 (USD Million)
• 5.4. Sports/Racing
  • 5.4.1. Sports/Racing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. Recreation
  • 5.5.1. Recreation Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Others
  • 5.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Equine Artificial Insemination Market: By Distribution Channel Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. U.S. Equine Artificial Insemination Market: By Distribution Channel Movement Analysis
• 6.3. U.S. Equine Artificial Insemination Market Size & Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
  • 6.3.1. Private
    • 6.3.1.1. Private Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.2. Public
    • 6.3.2.1. Public Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Market Participant Categorization
• 7.2. Company Market Position Analysis/ Heat Map Analysis
• 7.3. Company Profiles
  • 7.3.1. Neogen Corporation
    • 7.3.1.1. Participant's Overview
    • 7.3.1.2. Financial Performance
    • 7.3.1.3. Product/Service Benchmarking
    • 7.3.1.4. Strategic Initiatives
  • 7.3.2. Zoetis Services LLC
    • 7.3.2.1. Participant's Overview
    • 7.3.2.2. Financial Performance
    • 7.3.2.3. Product/Service Benchmarking
    • 7.3.2.4. Strategic Initiatives
  • 7.3.3. HOFFMAN A.I. BREEDERS INC
    • 7.3.3.1. Participant's Overview
    • 7.3.3.2. Financial Performance
    • 7.3.3.3. Product/Service Benchmarking
    • 7.3.3.4. Strategic Initiatives
  • 7.3.4. Nasco Healthcare
    • 7.3.4.1. Participant's Overview
    • 7.3.4.2. Financial Performance
    • 7.3.4.3. Product/Service Benchmarking
    • 7.3.4.4. Strategic Initiatives
  • 7.3.5. IMV Technologies
    • 7.3.5.1. Participant's Overview
    • 7.3.5.2. Financial Performance
    • 7.3.5.3. Product/Service Benchmarking
    • 7.3.5.4. Strategic Initiatives
  • 7.3.6. Continental Genetics, LLC
    • 7.3.6.1. Participant's Overview
    • 7.3.6.2. Financial Performance
    • 7.3.6.3. Product/Service Benchmarking
    • 7.3.6.4. Strategic Initiatives
  • 7.3.7. Olympia Equine Veterinary Services PLLC
    • 7.3.7.1. Participant's Overview
    • 7.3.7.2. Financial Performance
    • 7.3.7.3. Product/Service Benchmarking
    • 7.3.7.4. Strategic Initiatives
  • 7.3.8. Sarasota Equine Veterinary Services
    • 7.3.8.1. Participant's Overview
    • 7.3.8.2. Financial Performance
    • 7.3.8.3. Product/Service Benchmarking
    • 7.3.8.4. Strategic Initiatives
  • 7.3.9. Montana Equine Medical and Surgical Center
    • 7.3.9.1. Participant's Overview
    • 7.3.9.2. Financial Performance
    • 7.3.9.3. Product/Service Benchmarking
    • 7.3.9.4. Strategic Initiatives
  • 7.3.10. Select Breeders Services
    • 7.3.10.1. Participant's Overview
    • 7.3.10.2. Financial Performance
    • 7.3.10.3. Product/Service Benchmarking
    • 7.3.10.4. Strategic Initiatives
  • 7.3.11. Equine Reproduction Concepts, LLC
    • 7.3.11.1. Participant's Overview
    • 7.3.11.2. Financial Performance
    • 7.3.11.3. Product/Service Benchmarking
    • 7.3.11.4. Strategic Initiatives
  • 7.3.12. Wisconsin Valley Veterinary Service
    • 7.3.12.1. Participant's Overview
    • 7.3.12.2. Financial Performance
    • 7.3.12.3. Product/Service Benchmarking
    • 7.3.12.4. Strategic Initiatives
• 7.4. Strategy Mapping
  • 7.4.1. Mergers & Acquisitions
  • 7.4.2. Partnerships & Collaborations
  • 7.4.3. Product/Service launch
  • 7.4.4. Others
• 7.5. List of other key players

List of Tables

• Table 1 List of secondary sources
• Table 2 U.S. Equine Artificial Insemination Market, by Solution, 2021 - 2033 (USD Million)
• Table 3 U.S. Equine Artificial Insemination Market, by Equine, 2021 - 2033 (USD Million)
• Table 4 U.S. Equine Artificial Insemination Market, by Distribution Channel, 2021 - 2033 (USD Million)
• Table 5 Company Overview
• Table 6 Product Benchmarking
• Table 7 Financial Performance
• Table 8 Strategic Initiatives

List of Figures

• Fig. 1 Market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value chain-based sizing & forecasting
• Fig. 7 QFD modelling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 U.S. Equine Artificial Insemination Market revenue, 2021 - 2033 (USD Million)
• Fig. 10 U.S. Equine Artificial Insemination Market snapshot
• Fig. 11 U.S. Equine Artificial Insemination Market driver impact
• Fig. 12 U.S. Equine Artificial Insemination Market restraint impact
• Fig. 13 U.S. Equine Artificial Insemination species key takeaways (USD Million)
• Fig. 14 U.S. Equine Artificial Insemination Market: solution, market share 2024 & 2033
• Fig. 15 U.S. Equipment & Consumables market, 2021 - 2033 (USD Million)
• Fig. 16 Semen market, 2021 - 2033 (USD Million)
• Fig. 17 Normal market, 2021 - 2033 (USD Million)
• Fig. 18 Sexed market, 2021 - 2033 (USD Million)
• Fig. 19 Services market, 2021 - 2033 (USD Million)
• Fig. 20 U.S. Equine Artificial Insemination equine key takeaways (USD Million)
• Fig. 21 U.S. Equine Artificial Insemination Market: equine, market share 2024 & 2033
• Fig. 22 Sports/Racing market, 2021 - 2033 (USD Million)
• Fig. 23 Recreation market, 2021 - 2033 (USD Million)
• Fig. 24 Others market, 2021 - 2033 (USD Million)
• Fig. 25 U.S. Equine Artificial Insemination market by Distribution Channel: Key takeaways
• Fig. 26 U.S. Equine Artificial Insemination market by Distribution Channel, market share, 2024 & 2033
• Fig. 27 Private market, 2021 - 2033 (USD Million)
• Fig. 28 Public market, 2021 - 2033 (USD Million)
• Fig. 29 Market participant categorization
• Fig. 30 Market share of key market players U.S. Equine Artificial Insemination market